Načítá se...
Metformin: an antiproliferative agent and methylation regulator in treating prostatic disease?
Existing drugs that have been used in clinical practice for other purposes can prove useful for reutilization, since much of the safety profile and pharmacokinetics have been completed. Therefore, the drugs can enter clinical practice for a variety of causes with less regulatory burden. Metformin ma...
Uloženo v:
| Vydáno v: | Am J Physiol Renal Physiol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Physiological Society
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5899225/ https://ncbi.nlm.nih.gov/pubmed/29117997 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajprenal.00443.2017 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|